The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-bromophenyl)(2-hydroxy-4,6-dimethoxy-3-(pyrrolidin-1-ylmethyl)phenyl)methanone ID: ALA1091049
PubChem CID: 46884375
Max Phase: Preclinical
Molecular Formula: C20H22BrNO4
Molecular Weight: 420.30
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)c(C(=O)c2ccccc2Br)c(O)c1CN1CCCC1
Standard InChI: InChI=1S/C20H22BrNO4/c1-25-16-11-17(26-2)18(19(23)13-7-3-4-8-15(13)21)20(24)14(16)12-22-9-5-6-10-22/h3-4,7-8,11,24H,5-6,9-10,12H2,1-2H3
Standard InChI Key: OABYAGIMRITJGD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
18.1819 -15.9208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1807 -16.7482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8956 -17.1610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6120 -16.7477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6091 -15.9172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8938 -15.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4659 -17.1601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7518 -16.7470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8913 -14.6830 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6045 -14.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3271 -17.1591 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3221 -15.5020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0381 -15.9118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3189 -14.6770 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0378 -16.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7530 -17.1442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4669 -16.7289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4611 -15.8997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7454 -15.4937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7380 -14.6687 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
18.8954 -17.9860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1808 -18.3984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4277 -18.0659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8755 -18.6789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2879 -19.3935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0949 -19.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
1 2 2 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
19 20 1 0
9 10 1 0
3 21 1 0
2 3 1 0
21 22 1 0
22 23 1 0
4 11 1 0
5 6 2 0
5 12 1 0
6 1 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 420.30Molecular Weight (Monoisotopic): 419.0732AlogP: 4.00#Rotatable Bonds: 6Polar Surface Area: 59.00Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.99CX Basic pKa: 7.96CX LogP: 3.39CX LogD: 3.36Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: -0.20
References 1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143 ] [10.1016/j.bmcl.2010.02.001 ]